CTRI/2020/05/025013尚未招募2 期
Phase 2 Clinical Trial for the Evaluation of BCG as potential therapy for CoVID-I9 - COVID-19 BCG
Medical Education and Drugs Department0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Hospitalized subjects either male or female with confirmed COVID-19 will be included in this as per following criteria:
- •1.Age 20 - 50 years
- •2.Symptomatic subjects with fever (using self-reported questionnaire) plus at least one sign or symptom of respiratory disease including cough, shortness of breath, respiratory distress/failure, runny/blocked nose (using self-reported questionnaire), plus
- •3.Positive SARS-Cov-2 test in nasopharyngeal sample at admission (using RT-PCR as prescribed by WHO, ICMR and NCDC)
排除标准
- •Subjects outside the age group
- •Subjects who test negative for nCOV-19 by RT-PCR as per criteria laid down by ICMR.
- •Subjects with
- •1.Any co-morbidities such as renal distress, cardiac malfunction etc. at time of admission
- •2.Any disorder in which natural immune response is altered,
- •3.Systemic lupus
- •4.Hypogamma-globulinemia,
- •5.Congenital immunodeficiency,
- •6.Sarcoidosis,
- •7.Leukaemia,
- •8.Generalised malignancy,
- •9.HIV infections or as also those on immunosuppressive therapy, corticosteroids, radiotherapy.
- •10.Inchronic eczema or other dermatological disease
- •11.Pregnant women, lactating (breast-feeding) women
研究者
相似试验
进行中（未招募）
1 期
A study evaluating efficacy of the drug BGB-290 in patients with gastric cancer that responded to previous chemotherapyInoperable Locally Advanced or Metastatic Gastric Cancer that Responded to Platinum-based First-line ChemotherapyMedDRA version: 21.1Level: PTClassification code 10063916Term: Metastatic gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003493-13-GBBeiGene, Ltd.128
已完成
2 期
BGB-290-303Inoperable Locally Advanced or Metastatic GastricCancerJPRN-jRCT2080225173Beigene ( ICCC: Parexel International)11
进行中（未招募）
1 期
A study evaluating efficacy of the drug BGB-290 in patients with gastric cancer that responded to previous chemotherapyEUCTR2017-003493-13-PLBeiGene Ltd.128
进行中（未招募）
1 期
A study evaluating efficacy of the drug BGB-290 in patients with gastric cancer that responded to previous chemotherapyInoperable Locally Advanced or Metastatic Gastric Cancer that Responded to Platinum-based First-line ChemotherapyMedDRA version: 21.1Level: PTClassification code 10063916Term: Metastatic gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-003493-13-CZBeiGene, Ltd.540
进行中（未招募）
1 期
A study evaluating efficacy of the drug BGB-290 in patients with gastric cancer that responded to previous chemotherapy.EUCTR2017-003493-13-ESBeiGene Ltd.540